Chief Financial Officer · Voyager Therapeutics, Inc. (VYGR)

Ph Nathan Jorgensen

FY2024 is the first fiscal year CompBrief holds for Ph Nathan Jorgensen as a named executive officer of Voyager Therapeutics; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2024

$1,869,964

Salary $228,000Stock awards $468,000

3rd of 3 named executive officers at Voyager Therapeutics by FY2024 total.

3 named officers on file for Voyager Therapeutics, FY2024

Ph Nathan Jorgensen’s pay file — $29

  • 1 fiscal year of pay, line by line
  • VYGR’s disclosed peer group of 18 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Voyager Therapeutics’s whole pay program stands against its peers

  • Voyager Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on VYGR→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 23, 2025 (DEF 14A).

Free

Get Ph Nathan Jorgensen’s full pay file as a PDF — free

More than this page: up to 10 years of Ph’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Ph Nathan Jorgensen compensation by year

Voyager Therapeutics Summary Compensation Table · the one fiscal year held
In US dollars, as Voyager Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2024
Salary$228,000
Bonus$0
Stock awards$468,000
Option awards$1,070,000
Non-equity incentive$90,914
Pension and deferred compensation$0
All other$13,050
Total$1,869,964

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Voyager Therapeutics, Inc. DEF 14A filed April 23, 2025, accession 0001558370-25-005254, and prior-year filings.

How this page was built: the Voyager Therapeutics, Inc. filed document, accession 0001558370-25-005254. Every figure is read from that document and cited to the page and table it appears in. Filed April 23, 2025.

Voyager Therapeutics’s named executive officers, FY2024

as the company reported each
Named executive officerRoleFY2024 total
Alfred SandrockChief Executive Officer, President, and Director$3,377,401
Toby FergusonChief Medical Officer$2,969,200
Ph Nathan Jorgensen · this pageChief Financial Officer$1,869,964

The full Voyager Therapeutics compensation record

free company brief

This page is one person within Voyager Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Voyager Therapeutics proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Voyager Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Ph Nathan Jorgensen's compensation dossier · One-time report. No refunds.